|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
5 months to Dec 31, 2020
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net income | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||
| General and adminsitrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | |||
| General and adminsitrative expenses paid by Sponsor under note payable | |||
| Offering costs - derivative warrant liabilities | |||
| Gain on forgiveness of deferred underwriting commissions | |||
| Change in fair value of derivative warrant liabilities | |||
| Income from investments held in Trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accounts payable | |||
| Accrued expenses | |||
| Due to related party | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Cash deposited in Trust Account for extension | |||
| Cash withdrawn from Trust Account for redemptions | |||
| Net cash used in investing activities | |||
| Cash Flows Used in Financing Activities: | |||
| Loan proceeds received from note payable to sponsor | |||
| Proceeds received from note payable—related party | |||
| Proceeds received from private placement | |||
| Offering costs paid | |||
| Repayment of advances from related party | |||
| Repayment of note payable to Sponsor | |||
| Redemption of Class A ordinary shares | |||
| Net cash used in financing activities | |||
| Offering costs included in accounts payable | |||
| Offering costs included in accrued expenses | |||
| Offering costs included in note payable | |||
| Deferred underwriting commissions | |||
| Initial value of Class A ordinary shares subject to possible redemption | |||
| Change in initial value of Class A ordinary shares subject to possible redemption | |||
| Net change in cash | |||
| Cash—beginning of the year | |||
| Cash—end of the year | |||
| Supplemental disclosure of noncash investing and financing activities: | |||
| Extinguishment of deferred underwriting commissions allocated to Public Shares |
Loading...